Arthritis drug heart risks ‘could be avoidable’

5 July 2013

The higher risk of heart attacks or strokes which comes with many arthritis drugs could be avoidable, according to a new study.

Vioxx, diclofenac, ibuprofen and other common drugs taken by arthritis sufferers block the enzyme COX-2, the presence of which in blood vessels has been believed to create clots and thus contribute to the higher risk of heart problems.

But research carried out on mice by a team at Imperial College London found that COX-2 is usually missing from major blood vessels, but more likely to appear in the brain, intestines, kidneys and thymus gland.

Researchers say that now they have an idea of where the drug is acting, they now have scope to develop more targeted drugs that will be safer for arthritis sufferers.

Anti-inflammatory Vioxx was withdrawn in 2004 amid fears that concerns that it came with dangerous cardiovascular side-effects. More recently, regulators have warned certain patients off diclofenac for similar reasons.

Professor Jane Mitchell of Imperial’s Faculty of Medicine says that scientists could be working on potential leads within five to ten years.

Posted by Philip Briggs


Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.

Find a treatment, test or scan available at:


Find a consultant

Use one or more of the options below to search for a consultant and link through to view their Spire profile.


Let us help you

fill out this form and we will get back to you:

Please select a hospital

We can call you

Please enter your details below and we will call you back.

What is the aim of your enquiry?

Please select a hospital

If we are unable to reach you by phone, please include your email address so that we can get in touch...



© Spire Healthcare Group plc (2016)